IMA
Price
$4.62
Change
+$0.03 (+0.65%)
Updated
Oct 2, 04:56 PM (EDT)
Capitalization
52.67M
40 days until earnings call
Intraday BUY SELL Signals
MNOV
Price
$1.80
Change
+$0.17 (+10.43%)
Updated
Oct 2, 04:59 PM (EDT)
Capitalization
101.89M
41 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMA vs MNOV

IMA vs MNOV Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMA vs. MNOV commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMA is a Hold and MNOV is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
MNOV: Fundamental Ratings
MNOV
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
42
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
38
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMAMNOV
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
74%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
68%
Advances
ODDS (%)
Bullish Trend 16 days ago
79%
Bullish Trend 16 days ago
64%
Declines
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 2 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
78%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
79%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (IMA: $4.59 vs. MNOV: $1.63)
Brand notoriety: IMA and MNOV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMA: 94% vs. MNOV: 59%
Market capitalization -- IMA: $52.67M vs. MNOV: $101.89M
IMA [@Biotechnology] is valued at $52.67M. MNOV’s [@Biotechnology] market capitalization is $101.89M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMA’s FA Score shows that 1 FA rating(s) are green while MNOV’s FA Score has 0 green FA rating(s).

  • IMA’s FA Score: 1 green, 4 red.
  • MNOV’s FA Score: 0 green, 5 red.
According to our system of comparison, MNOV is a better buy in the long-term than IMA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMA’s TA Score shows that 4 TA indicator(s) are bullish while MNOV’s TA Score has 4 bullish TA indicator(s).

  • IMA’s TA Score: 4 bullish, 4 bearish.
  • MNOV’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, IMA is a better buy in the short-term than MNOV.

Price Growth

IMA (@Biotechnology) experienced а -1.08% price change this week, while MNOV (@Biotechnology) price change was -38.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.63%. For the same industry, the average monthly price growth was -14.35%, and the average quarterly price growth was -1.64%.

Reported Earning Dates

IMA is expected to report earnings on Nov 11, 2026.

MNOV is expected to report earnings on Nov 12, 2026.

Industries' Descriptions

@Biotechnology (-3.63% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IMA
Daily Signal:
Gain/Loss:
MNOV
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
GDXD23.060.86
+3.87%
MicroSectors Gold Miners - 3X Inverse Leveraged ETNs (GDXD)
FLYD56.291.12
+2.03%
MicroSectors Travel - 3x Inverse Leveraged ETN (FLYD)
FTLS76.900.21
+0.27%
First Trust Long/Short Equity ETF (FTLS)
JULZ46.02-0.08
-0.16%
TrueShares Structured Outcome (July) ETF (JULZ)
JPRE49.13-0.28
-0.57%
JPMorgan Realty Income ETF (JPRE)

IMA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMA has been closely correlated with CELC. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if IMA jumps, then CELC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMA
1D Price
Change %
IMA100%
+0.22%
CELC - IMA
77%
Closely correlated
-5.52%
SLXN - IMA
62%
Loosely correlated
+0.61%
SYRE - IMA
34%
Loosely correlated
+1.01%
RAPP - IMA
31%
Poorly correlated
-2.29%
RVMD - IMA
29%
Poorly correlated
+0.31%
More

MNOV and

Correlation & Price change

A.I.dvisor indicates that over the last year, MNOV has been loosely correlated with FATE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MNOV jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MNOV
1D Price
Change %
MNOV100%
-2.69%
FATE - MNOV
36%
Loosely correlated
-2.95%
NCEL - MNOV
36%
Loosely correlated
-0.34%
ARDX - MNOV
33%
Loosely correlated
-1.17%
VIR - MNOV
29%
Poorly correlated
+0.98%
IMA - MNOV
28%
Poorly correlated
+0.22%
More